To Investigate the Effects of AZD1981 on the QT Interval

NCT01265641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: AZD1981, 2000mg
DRUG: AZD1981, 200mg
DRUG: Moxifloxacin, 400mg
DRUG: Placebo

Sponsor

AstraZeneca